That is an intelligent and thoughtful post. That should be a sticky.
How many times do I have to say this: I believe that all of these ActiPatch studies are underpowered (sample size too small), which means the positive results are suspect and the negative results are suspect.
The CMS and the rest of the insurance industry agree with me, and that's why the device is not covered by insurance.
Market Data 
Markets 
AI
